Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center at San Antonio
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of schizophrenia or schizoaffective disorder or bipolar disorder
BMI\>29.9 or family history of diabetes and/or abdominal circumference greater than 88 cm in women or 102 cm in men
Pre-diabetic oral glucose tolerance test
Current treatment with olanzapine, risperidone, paliperidone, or quetiapine, or combination of these
Willing to switch to ziprasidone
No psychiatric hospitalizations in past three months and judged by treating clinician to be suitable for antipsychotic medication switch
Able to give informed consent to study
You may not be if
Judged to be currently suicidal, homicidal, or unable to cooperate with treatment
Unstable serious medical illness
Current use of drugs that interfere with glucose and fat metabolism (sulfonylureas, metformin, thiazolidinediones). The use of "statins" and fibrates will be allowed ONLY if stable dose for past 3 months.
Current diagnosis of diabetes
Fasting blood glucose \>125 mg/dl
Clareo Health | Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
